Rida Kherati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rida Kherati has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Kadir
Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK
1 shared publicationArchana Bansal
Department of Paediatric Gastroenterology, Clinical Research Facility, Barts Health NHS Trust The Royal London Children's Hospital London UK
1 shared publicationJulia Oleksiewicz
Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK
1 shared publication- Marco Gasparetto
Department of Paediatric Gastroenterology Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals, Faculty of Medicine and Health Science University of East Anglia (UEA) Norwich UK
1 shared publication Natasha Burgess
Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK
1 shared publicationNicholas M Croft
Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK
1 shared publication
Latest Publications
- Open Access
- 4 January 2024
- Published by Wiley in JPGN Reports
- Vol. 5 (1) , 17-28
The impact of age, disease severity, and BMI on bone health and growth in children and young people with Crohn's disease
The objective of this study was to explore the correlation between paediatric Crohn's disease (CD) characteristics, bone health and growth parameters at diagnosis and follow‐up. Retrospective data was collected for 47 children aged 4–16 who were newly diagnosed with CD between January 2018 and December 2019. Mean follow‐up time was 2.5 years. Eleven (24%) children had growth delay at diagnosis, which persisted in 4 (44%) of 9 recorded children at follow‐up. Of the 35 children tested, 20 (57%) had inadequate Vitamin D levels (<50 mmol/L) at diagnosis. Thirty‐seven (79%) children had a dual‐energy X‐ray absorptiometry scan at diagnosis, with 20 of them having at least 1 low Z‐score. Children with poorer bone mineral density and bone mineral concentration Z‐scores for age had a younger age at diagnosis (p = .042 and p = .021), more severe disease (p = .04 and p = .029) and a lower BMI (p < .001) at diagnosis. Children diagnosed with CD ≥11 years had a lower‐than‐expected height velocity (p < .0001 and p < .001). Multivariate regression analysis demonstrated an older age of diagnosis was a significant predictor of a lower height velocity at follow‐up. Disease severity and age of diagnosis are important CD‐related factors that influence bone health and growth. Vitamin D is an accessible component that if optimised can improve all three factors. Monitoring and optimising each aspect systematically has the potential to enable children to achieve their bone health and growth potentials. Growth failure occurs in up to 85% of children diagnosed with Crohn's disease and persists in up to 40%. Vitamin D plays a role in bone health (BH), growth, and intestinal inflammation. Chronic inflammation and undernutrition are key factors behind poor BH and growth failure. Children with poorer BH are younger, have more severe disease and a lower body mass index at diagnosis. An older age of diagnosis is an independent predictor of lower‐than‐expected height velocity in the future.
- 4 January 2024
- Published by Wiley in JPGN Reports
- Vol. 5 (1) , 17-28
Open AccessThe impact of age, disease severity, and BMI on bone health and growth in children and young people with Crohn's disease
The objective of this study was to explore the correlation between paediatric Crohn's disease (CD) characteristics, bone health and growth parameters at diagnosis and follow‐up. Retrospective data was collected for 47 children aged 4–16 who were newly diagnosed with CD between January 2018 and December 2019. Mean follow‐up time was 2.5 years. Eleven (24%) children had growth delay at diagnosis, which persisted in 4 (44%) of 9 recorded children at follow‐up. Of the 35 children tested, 20 (57%) had inadequate Vitamin D levels (<50 mmol/L) at diagnosis. Thirty‐seven (79%) children had a dual‐energy X‐ray absorptiometry scan at diagnosis, with 20 of them having at least 1 low Z‐score. Children with poorer bone mineral density and bone mineral concentration Z‐scores for age had a younger age at diagnosis (p = .042 and p = .021), more severe disease (p = .04 and p = .029) and a lower BMI (p < .001) at diagnosis. Children diagnosed with CD ≥11 years had a lower‐than‐expected height velocity (p < .0001 and p < .001). Multivariate regression analysis demonstrated an older age of diagnosis was a significant predictor of a lower height velocity at follow‐up. Disease severity and age of diagnosis are important CD‐related factors that influence bone health and growth. Vitamin D is an accessible component that if optimised can improve all three factors. Monitoring and optimising each aspect systematically has the potential to enable children to achieve their bone health and growth potentials. Growth failure occurs in up to 85% of children diagnosed with Crohn's disease and persists in up to 40%. Vitamin D plays a role in bone health (BH), growth, and intestinal inflammation. Chronic inflammation and undernutrition are key factors behind poor BH and growth failure. Children with poorer BH are younger, have more severe disease and a lower body mass index at diagnosis. An older age of diagnosis is an independent predictor of lower‐than‐expected height velocity in the future.